- EMA Recommends Granting a Marketing Authorisation for Generic Imatinib
- TAT 2018: Programme
- TAT 2018: Abstracts
- Withdrawal of the Application for a Change to the Marketing Authorisation for Nivolumab in EU
- EMA Recommends Granting a Marketing Authorisation for Trastuzumab Biosimilar
- ESMO Press Release: ESMO announces new interim Editor-in-Chief of Annals of Oncology
As well as peer-reviewed journals, touchONCOLOGY also provide video interviews, procedures and general updates on the latest trends within the area, as well as featuring carefully selected video from our partners.
Sharleen Gill discusses the latest developments in pancreatic cancer and the current treatment guidelines.
Editorial Board member Bernardo Rapoport talks about his favourite features of European Oncology & Haematology and touchONCOLOGY.com
We are delighted to introduce Axel Merseburger, the new Editor-in-Chief of European Oncology & Haematology.
Paolo Asceirto discusses the challenges and recent advances in the treatment of advanced melanoma.
Iain McNeish discusses the role of PARP inhibitors, including rucaparib in the treatment of ovarian cancer.
Ahmad Awada discusses the current and future developments in immunotherapy.
Marwan Fakih discusses the implications of primary tumour location on biological therapy in metastatic colorectal cancer.
Frédérique Penault Llorca discusses the latest research into biomarkers and the predictability of immunotherapy response.
Dr Andrew Hendifar reviews the adverse events associated with PEGPH20 (pegvorhyaluronidase alfa), and the future application of PEGPH20 in different cancers This video was supported by Halozyme. Filmed at the American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, US, June 2017...
Dr Andrew Hendifar discusses targeting tumor hyaluronan with PEGPH20 (pegvorhyaluronidase alfa) in preclinical models and in human tissue. He discusses the results of the recent phase II study of PEGPH20 in combination with gemcitabine and nab-paclitaxel. This video was supported by Halozyme...
Dr Andrea Bullock explains the role of hyaluronic acid in the peritumoral stroma of pancreatic cancer. She also explains how hyaluronidase works against hyaluronan to normalize blood flow to the tumor. Finally she discusses the longer half-life of the pegylated version (PEGPH20; pegvorhyaluronidase...
Dr Andrea Bullock summarizes the difficulties in diagnosing and treating pancreatic cancer, and the composition of the tumor cells in pancreatic cancer. This video was supported by Halozyme. Filmed at the American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, US, June 2017
Dr Matti Aapro, from our Editorial Board, discusses supportive treatment with granulocyte-colony stimulating factor (G-CSF) in chemo-sensitive tumors, and also guidelines for the prevention and treatment of febrile neutropenia. Support: The filming of this video was supported by Accord...